Suppr超能文献

[哌拉西林在早产儿中的剂量与消除]

[Piperacillin dosage and elimination in premature infants].

作者信息

Franek A, Cullmann W

机构信息

Kinderklinik im Marienhospital Bottrop.

出版信息

Dtsch Med Wochenschr. 1987 Oct 23;112(43):1652-7. doi: 10.1055/s-2008-1068307.

Abstract

In 19 premature newborns (mean birth weight 1600 g, range 800-2430 g), receiving a daily dose of 100-150 mg piperacillin/kg body weight in four divided doses, serum concentration of the drug at the end of its interval of administration was a mean of 32.6 +/- 25.0 mg/l. In six mature newborns it was lower at 12.5 +/- 9.0 mg/l. The mean serum drug level on days 1, 5 and 10 in ten premature newborns at the end of the respective interval of administration was reduced to about 69% of the initial level. Elimination of piperacillin (half-life and clearance) was determined in the middle of their first week of treatment in 11 prematures. Compared with values in adults, mean half-life was increased fourfold. In individual cases it was increased tenfold. Compared with a control group of mature newborns, clearance was markedly reduced. Because of the danger of underdosage as a result of increasing maturation of elimination during the period of treatment, piperacillin should be given in slightly higher doses, 200-300 mg/kg in premature and mature newborns. However, the clearly prolonged half-life makes it possible to divide daily dosage into two doses.

摘要

19名早产新生儿(平均出生体重1600克,范围800 - 2430克),接受每日剂量为100 - 150毫克哌拉西林/千克体重,分四次给药,给药间隔结束时药物血清浓度平均为32.6±25.0毫克/升。6名足月新生儿的该浓度较低,为12.5±9.0毫克/升。10名早产新生儿在第1、5和10天各自给药间隔结束时的平均血清药物水平降至初始水平的约69%。在11名早产儿治疗的第一周中期测定了哌拉西林的消除情况(半衰期和清除率)。与成人的值相比,平均半衰期增加了四倍。个别情况下增加了十倍。与足月新生儿对照组相比,清除率明显降低。由于在治疗期间消除过程的成熟度增加可能导致剂量不足的风险,早产和足月新生儿应给予稍高剂量的哌拉西林,即200 - 300毫克/千克。然而,明显延长的半衰期使得每日剂量可以分为两次给药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验